An indirect role for oncomir-519b in the expression of truncated neurokinin-1 in breast cancer cells
- PMID: 22981979
- PMCID: PMC3645290
- DOI: 10.1016/j.yexcr.2012.09.002
An indirect role for oncomir-519b in the expression of truncated neurokinin-1 in breast cancer cells
Abstract
Neurokinin 1 (NK1) encodes full-length (NK1-FL) and truncated (NK1-Tr) receptors, with distinct 3' UTR. NK1-Tr exerts oncogenic functions and is increased in breast cancer (BC). Enhanced transcription of NK1 resulted in higher level of NK1-Tr. The 3' UTR of these two transcripts are distinct with NK1-Tr terminating at a premature stop codon. NK1-Tr mRNA gained an advantage over NK1-FL with regards to translation. This is due to the ability of miR519B to interact with sequences within the 3' UTR of NK1-FL, but not NK1-Tr since the corresponding region is omitted. MiR519b suppressed the translation of NK1-FL in T47D and MDA-MB-231 resulting in increased NK1-Tr protein. Cytokines can induce the transcription of NK1. However, our studies indicated that translation appeared to be independent of cytokine production by the BC cells (BCCs). This suggested that transcription and translation of NK1 might be independent. The findings were validated in vivo. MiR-519b suppressed the growth of MDA-MB-231 in 7/10 nude BALB/c. In total, increased NK1-Tr in BCCs is due to enhanced transcription and suppressed translation of NK1-FL by miR-519b to reduced tumor growth. In summary, we report on miRNA as a method to further regulate the expression of a spiced variant to promote oncogenesis. In addition, the findings have implications for therapy with NK1 antagonists. The oncogenic effect of NK1-Tr must be considered to improve the efficacy of current drugs to NK1.
Copyright © 2012 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest
Figures







Similar articles
-
Nuclear factor-kappaB is central to the expression of truncated neurokinin-1 receptor in breast cancer: implication for breast cancer cell quiescence within bone marrow stroma.Cancer Res. 2007 Feb 15;67(4):1653-9. doi: 10.1158/0008-5472.CAN-06-3813. Cancer Res. 2007. PMID: 17308106
-
Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides.Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17436-41. doi: 10.1073/pnas.0506351102. Epub 2005 Nov 16. Proc Natl Acad Sci U S A. 2005. PMID: 16291810 Free PMC article.
-
MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.Cell Prolif. 2019 Jan;52(1):e12527. doi: 10.1111/cpr.12527. Epub 2018 Oct 17. Cell Prolif. 2019. PMID: 30334298 Free PMC article.
-
Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.Breast Cancer Res Treat. 2013 Jul;140(1):49-61. doi: 10.1007/s10549-013-2599-6. Epub 2013 Jun 27. Breast Cancer Res Treat. 2013. PMID: 23807418
-
MicroRNA-22 inhibits proliferation, invasion and metastasis of breast cancer cells through targeting truncated neurokinin-1 receptor and ERα.Life Sci. 2019 Jan 15;217:57-69. doi: 10.1016/j.lfs.2018.11.057. Epub 2018 Nov 28. Life Sci. 2019. PMID: 30502362
Cited by
-
Association of Neurokinin-1 Receptor Signaling Pathways with Cancer.Curr Med Chem. 2024;31(39):6460-6486. doi: 10.2174/0929867331666230818110812. Curr Med Chem. 2024. PMID: 37594106 Review.
-
miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819875168. doi: 10.1177/1533033819875168. Technol Cancer Res Treat. 2019. PMID: 31506061 Free PMC article.
-
Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer.Noncoding RNA. 2020 Jul 13;6(3):29. doi: 10.3390/ncrna6030029. Noncoding RNA. 2020. PMID: 32668603 Free PMC article. Review.
-
Plasma microRNA markers of upper limb recovery following human stroke.Sci Rep. 2018 Aug 22;8(1):12558. doi: 10.1038/s41598-018-31020-5. Sci Rep. 2018. PMID: 30135469 Free PMC article.
-
Increased expression of musashi 1 on breast cancer cells has implication to understand dormancy and survival in bone marrow.Aging (Albany NY). 2023 Mar 29;15(9):3230-3248. doi: 10.18632/aging.204620. Epub 2023 Mar 29. Aging (Albany NY). 2023. PMID: 36996499 Free PMC article.
References
-
- Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA Cancer J Clin. 2010;61:133–134. - PubMed
-
- Munoz M, Rosso M, Covenas R. A new frontier in the treatment of cancer: NK-1 receptor antagonists. Curr Med Chem. 2010;17:504–516. - PubMed
-
- Brener S, Gonzalez-Moles MA, Tostes D, Esteban F, Gil-Montoya JA, Ruiz-Avila I, Bravo M, Munoz M. A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma. Anticancer Res. 2009;29:2323–2329. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous